Carbopa – Carboplatin Injection
CARBOPLATIN (CARBOPA) INJECTION – TREATMENT FOR MULTIPLE CANCER
Both small cell lung cancer and ovarian cancer are treated with Carbopa injection. By halting or reducing the growth of cancer cells, it demonstrates its effectiveness.
Under the direction of a doctor, Carbopa injection is administered as an injection into veins. Your doctor will determine the appropriate dosage and frequency of administration for you. This is based on the condition you are being treated for and is subject to change.
USES OF CARBOPLATIN (CARBOPA) INJECTION
- Ovarian cancer
- Small cell lung cancer
WORKS OF CARBOPLATIN (CARBOPA) INJECTION
An anti-cancer drug is Carbopa injection. It functions by causing harm to the cancer cell’s DNA and RNA, which prevents further growth and division of the cancer cells.
SIDE EFFECTS OF CARBOPLATIN (CARBOPA) INJECTION
- Anemia (low number of red blood cells)
- Low blood platelets
- Increased liver enzymes
- Decreased white blood cell count (neutrophils)
- Stomatitis (Inflammation of the mouth)
- Peripheral neuropathy (tingling and numbness of feet and hands)
WARNING & PRECAUTIONS
The injection of Carbopa may cause sleepiness and dizziness as well as a reduction in attentiveness and vision problems. If you experience these symptoms, don’t drive.
Using Carbopa injection while pregnant is dangerous because there is clear evidence that it poses a risk to the unborn child. However, if the advantages outweigh the possible risks, a doctor might very rarely recommend it in specific life-threatening circumstances. Please speak with your physician.
Fedelty Health Care is a Carboplatin third-party manufacturer, bulk pharma exporter, and pharmaceutical contract manufacturer operating businesses in Venezuela, Saudi Arabia, Cambodia, Oman, Brazil, Lebanon, Chile, Peru, Cuba, and Fiji. Other services they provide are hospital supply, government supply, named patient supply, cold chain supply, and drop shipping.